Pharma Explained

Pharma Explained

Download on the App Store

Pharma Explained episodes

  • Two Injections at an Affordable Price: What Could Go Wrong?

    Got something to say to this podcast? Send a voicemail, and you might hear yourself on the next episode!

    Two injections a year instead of a daily pill. Sounds like a big win for HIV prevention, but will it actually reach the people who need it? And what should happen to a medicine the moment a lab says it failed? In this episode of Pharma Explained, we break down both.

    We’ll cover:

    • What a tentative US FDA approval means for Dr. Reddy’s generic HIV prevention injection.
    • Why the partners expect a price of $40 per person per year.
    • How India’s draft rule could let regulators suspend a manufacturing licence right after a failed lab test.
    • What we still don’t know, including India’s own approval and the appeal route for the draft rule.
    • On the radar: new cancer drug prices from Monday 9th November.

    For the detailed stories, with sources and full numbers, visit the Pharma Now website and mobile app.

    Follow Pharma Now’s social handles:

    • LinkedIn: ⁠⁠⁠https://www.linkedin.com/company/pharma-now/?viewAsMember=true⁠⁠⁠
    • Facebook: ⁠⁠⁠https://www.facebook.com/profile.php?id=61559659700692⁠⁠⁠
    • X: ⁠⁠⁠https://x.com/PharmaNowGlobal⁠⁠⁠
    • Instagram: ⁠⁠⁠https://www.instagram.com/pharmanow.live/⁠⁠⁠

    Note: This content is for informational purposes only and is not medical advice. Talk to your doctor or pharmacist about your own treatment. None of the companies or products mentioned are recommendations or endorsements.

    7 min
  • When Your Data Leaks, Will Anyone Tell You? India’s DPDP Act Explained

    Got something to say to this podcast? Send a voicemail, and you might hear yourself on the next episode!

    In today’s episode of Pharma Explained, by Pharma Now, we cover a deep dive and another story shaping Indian and global pharma.

    We’ll cover:

    • How India’s data protection law (the DPDP Act) switches on in three steps.
    • What companies must do with your data, including consent and breach alerts.
    • What it may mean for trial participants, patients and pharma companies.
    • Why penalties can go up to Rs 250 crore.
    • The Supreme Court challenge that could still change the law.
    • What we still don’t know about clinical data and the Data Protection Board.

    For the detailed stories, with sources and full numbers, visit the Pharma Now website and mobile app.

    Follow Pharma Now’s social handles:

    • LinkedIn: ⁠⁠⁠https://www.linkedin.com/company/pharma-now/?viewAsMember=true⁠⁠⁠
    • Facebook: ⁠⁠⁠https://www.facebook.com/profile.php?id=61559659700692⁠⁠⁠
    • X: ⁠⁠⁠https://x.com/PharmaNowGlobal⁠⁠⁠
    • Instagram: ⁠⁠⁠https://www.instagram.com/pharmanow.live/⁠⁠⁠

    Note: This content is for informational purposes only and is not medical advice. Talk to your doctor or pharmacist about your own treatment. None of the companies or products mentioned are recommendations or endorsements.

    7 min
  • Why are Cancer Drugs Prices Falling, and Who Misses Out on a $40 HIV Shot?

    Got something to say to this podcast? Send a voicemail, and you might hear yourself on the next episode!

    In today’s episode of Pharma Explained, by Pharma Now, we cover a deep dive and another story shaping Indian and global pharma.

    We’ll cover:

    • How the government has limited what distributors and chemists can add to the price of cancer drugs.
    • Why one breast cancer medicine goes from Rs 696 to Rs 73.
    • What a tentative US FDA approval means for Dr. Reddy’s generic HIV prevention injection.
    • Why some groups say other countries are left out of the $40 price.
    • What we still don’t know about supply, savings and access.

    Audio Timestamps

    00:00 Intro

    00:18 Why are cancer drug prices falling?

    04:20 Who misses out on the HIV shot?

    05:40 On the radar

    06:00 What to watch

    For the detailed stories, with sources and full numbers, visit the Pharma Now website and mobile app.

    Follow Pharma Now’s social handles:

    • LinkedIn: ⁠⁠⁠https://www.linkedin.com/company/pharma-now/?viewAsMember=true⁠⁠⁠
    • Facebook: ⁠⁠⁠https://www.facebook.com/profile.php?id=61559659700692⁠⁠⁠
    • X: ⁠⁠⁠https://x.com/PharmaNowGlobal⁠⁠⁠
    • Instagram: ⁠⁠⁠https://www.instagram.com/pharmanow.live/⁠⁠⁠

    Note: This content is for informational purposes only and is not medical advice. Talk to your doctor or pharmacist about your own treatment. None of the companies or products mentioned are recommendations or endorsements.

    7 min

About Pharma Explained

From the publisher's feed

Pharma moves fast. Prices get capped, factories get inspected, a new injection gets a nod from a regulator on the other side of the world. And somewhere in all of that is a person picking up a…